Bednarikova, M.; Vinklerova, P.; Gottwaldova, J.; Ovesna, P.; Hausnerova, J.; Minar, L.; Felsinger, M.; Valik, D.; Cermakova, Z.; Weinberger, V.
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer. J. Clin. Med. 2021, 10, 2640.
https://doi.org/10.3390/jcm10122640
AMA Style
Bednarikova M, Vinklerova P, Gottwaldova J, Ovesna P, Hausnerova J, Minar L, Felsinger M, Valik D, Cermakova Z, Weinberger V.
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer. Journal of Clinical Medicine. 2021; 10(12):2640.
https://doi.org/10.3390/jcm10122640
Chicago/Turabian Style
Bednarikova, Marketa, Petra Vinklerova, Jana Gottwaldova, Petra Ovesna, Jitka Hausnerova, Lubos Minar, Michal Felsinger, Dalibor Valik, Zdenka Cermakova, and Vit Weinberger.
2021. "The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer" Journal of Clinical Medicine 10, no. 12: 2640.
https://doi.org/10.3390/jcm10122640
APA Style
Bednarikova, M., Vinklerova, P., Gottwaldova, J., Ovesna, P., Hausnerova, J., Minar, L., Felsinger, M., Valik, D., Cermakova, Z., & Weinberger, V.
(2021). The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer. Journal of Clinical Medicine, 10(12), 2640.
https://doi.org/10.3390/jcm10122640
